WITHDRAWN: EpiSemoLLM: A Fine-tuned Large Language Model for Epileptogenic Zone

Competing Interest Statement

Dr. Rosenow has received research support from the Federal State of Hesse, specifically at the Center for Personalized Translational Epilepsy Research from 2018 to 2022. Dr. Rosenow has received research support from Chaja-Foundation Frankfurt, focusing on establishing and evaluating the ketogenic diet in an institution. Dr. Rosenow received research support from Reiss-Foundation Frankfurt, mainly for the research on the ketogenic diet in GLUT1-DS. Dr. Rosenow received research support from German Ministry of Education, focusing on the ERAPerMed Raise-Genic.

Funding Statement

Research reported in this publication was partially supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health, United States under Award Number R21NS135482 (PI: Liu). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The approval of this secondary data analysis study was exempted by the Institutional Review Board (IRB) at Stevens Institute of Technology under protocol 2024-039 (N).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes